Psykey, Inc. (OTCMKTS:CEOS) Sees Significant Decline in Short Interest

Psykey, Inc. (OTCMKTS:CEOS) saw a large decrease in short interest during the month of November. As of November 15th, there was short interest totalling 2,400 shares, a decrease of 79.8% from the October 31st total of 11,900 shares. Based on an average daily trading volume, of 877,900 shares, the short-interest ratio is presently 0.0 days.

Psykey Stock Up 3.7 %

Psykey stock traded up $0.00 during trading hours on Friday, hitting $0.03. The stock had a trading volume of 1,163,104 shares, compared to its average volume of 577,683. The stock’s 50-day moving average price is $0.02 and its 200-day moving average price is $0.02. Psykey has a 12-month low of $0.01 and a 12-month high of $0.05.

About Psykey

Psykey, Inc engages in the research, development, and commercialization of entheogenic, adaptogenic, and nootropic ingredients and formulations for its functional product lines to improve and optimize life. The company also engages in the development of technologies for the composition, bioavailability, and targeted delivery of entheogen-based therapeutics for the psychedelic market.